JP2020505352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505352A5 JP2020505352A5 JP2019538525A JP2019538525A JP2020505352A5 JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5 JP 2019538525 A JP2019538525 A JP 2019538525A JP 2019538525 A JP2019538525 A JP 2019538525A JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5
- Authority
- JP
- Japan
- Prior art keywords
- alpha
- asn
- phe
- trp
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022193564A JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447778P | 2017-01-18 | 2017-01-18 | |
| US62/447,778 | 2017-01-18 | ||
| PCT/US2018/014257 WO2018136646A1 (en) | 2017-01-18 | 2018-01-18 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Division JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505352A JP2020505352A (ja) | 2020-02-20 |
| JP2020505352A5 true JP2020505352A5 (enExample) | 2021-02-25 |
Family
ID=62908287
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538525A Withdrawn JP2020505352A (ja) | 2017-01-18 | 2018-01-18 | インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Active JP7819087B2 (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200207822A1 (enExample) |
| EP (2) | EP3570864B1 (enExample) |
| JP (3) | JP2020505352A (enExample) |
| AU (1) | AU2018210174B2 (enExample) |
| CA (1) | CA3049889A1 (enExample) |
| ES (1) | ES3065770T3 (enExample) |
| WO (1) | WO2018136646A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2016054445A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| JP2017535527A (ja) | 2014-10-01 | 2017-11-30 | プロタゴニスト セラピューティクス， インコーポレイテッド | 新規のα４β７ペプチド単量体及び二量体拮抗薬 |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| SI3464336T1 (sl) | 2016-06-01 | 2022-06-30 | Athira Pharma, Inc. | Spojine |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CA3104418A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) * | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| SMT202500254T1 (it) * | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| MX2022008740A (es) * | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
| CA3226539A1 (en) * | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor |
| AU2022402440A1 (en) | 2021-12-01 | 2024-05-30 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2024003313A1 (en) | 2022-06-30 | 2024-01-04 | Sanofi | New peptides as selective il-23 receptor antagonists |
| WO2024015958A1 (en) * | 2022-07-14 | 2024-01-18 | Janssen Pharmaceutica Nv | Cyclic peptide inhibitors of il-23 |
| CN120529897A (zh) * | 2023-01-16 | 2025-08-22 | 詹森药业有限公司 | 白介素-23受体的脂化肽抑制剂的制剂 |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| AU2025218720A1 (en) | 2024-02-06 | 2026-05-21 | Paragon Therapeutics, Inc. | Il-23 antibody compositions and methods of use |
| WO2025171006A1 (en) | 2024-02-06 | 2025-08-14 | Paragon Therapeutics, Inc. | Il-23 binding protein compositions and methods of use |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026026815A1 (zh) * | 2024-07-30 | 2026-02-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂及其用途 |
| WO2026057052A1 (zh) * | 2024-09-14 | 2026-03-19 | 深圳信立泰药业股份有限公司 | 一种il-23受体抑制剂及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166138A1 (en) * | 2002-02-21 | 2003-09-04 | Todd Kinsella | Cyclic peptides and analogs useful to treat allergies |
| NZ578948A (en) | 2007-02-15 | 2012-03-30 | Univ Indiana Res & Tech Corp | Glucagon/glp-1 receptor co-agonists |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| SG10201810154WA (en) * | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| HK1257747A1 (zh) | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US20200064357A1 (en) * | 2016-11-09 | 2020-02-27 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
-
2018
- 2018-01-18 JP JP2019538525A patent/JP2020505352A/ja not_active Withdrawn
- 2018-01-18 ES ES18741939T patent/ES3065770T3/es active Active
- 2018-01-18 US US16/478,733 patent/US20200207822A1/en not_active Abandoned
- 2018-01-18 EP EP18741939.5A patent/EP3570864B1/en active Active
- 2018-01-18 AU AU2018210174A patent/AU2018210174B2/en active Active
- 2018-01-18 EP EP26158770.3A patent/EP4755908A2/en active Pending
- 2018-01-18 WO PCT/US2018/014257 patent/WO2018136646A1/en not_active Ceased
- 2018-01-18 CA CA3049889A patent/CA3049889A1/en active Pending
-
2022
- 2022-12-02 JP JP2022193564A patent/JP7819087B2/ja active Active
-
2023
- 2023-01-13 US US18/097,077 patent/US20240132558A1/en not_active Abandoned
-
2025
- 2025-05-28 JP JP2025088409A patent/JP2025162551A/ja active Pending